Vivasor Appoints JP3E Development Corp. (JP 3E Holdings, Inc. (JPTE) Majority Owned Subsidiary) as Exclusive Strategic Representative in the Republic of Korea
Strategic Partnership to Accelerate Korean Market Entry, Business Development, and Long-Term Value Creation Across Vivasor’s $100 Billion Pipeline of Clinical-Stage Biopharmaceutical Assets PR Audio SAN DIEGO, California and SEOUL, Republic of Korea, July 22, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Vivasor, Inc. (“Vivasor”), a clinical-stage biopharmaceutical holding company advancing […]